FDA Drug Recalls and Warnings: Illegal GLP-1 Sales and Misleading Marketing by Novo Nordisk and Eli Lilly
FDA Drug Recalls and Warnings: Illegal GLP-1 Sales and Misleading Marketing by Novo Nordisk and Eli Lilly
FDAFDA Drug Recalls and Warnings: Illegal GLP-1 Sales and Misleading Marketing by Novo Nordisk and Eli LillyKatie Rowley
MedShadow ArticlesCan I Take Amiodarone (Pacerone) and Atorvastatin (Lipitor) Together?Amy Gragnolati, PharmD
MedShadow ArticlesFDA SIDE EFFECTS UPDATE: Testosterone Drugs and High Blood Pressure RiskKatie Rowley
MedShadow ArticlesINVESTIGATING GENERICS: Real People Share Their Struggles With Generic ADHD MedicationsEmma Yasinski
MedShadow ArticlesWill Taking Tylenol During Pregnancy Harm Your Baby? The Evidence Is ComplicatedEmma Yasinski
NewsINVESTIGATING GENERICS: Senate Probes Drug Manufacturing Failures and Risks to U.S. SupplyEmma Yasinski
FDAFDA Drug Recalls and Warnings: Recalls for Compounded Semaglutide and Tirzepatide, Wegovy; Facility Warning LettersKatie Rowley
MedShadow ArticlesINVESTIGATING GENERICS: Two-Thirds of Americans Would Pay More for Safer DrugsLisa Jaycox
MedShadow ArticlesThe Truth About Supplements: Safety, Oversight, and the FDA’s RoleAmy Gragnolati, PharmD